Literature DB >> 33960944

Rates and Risk Factors for Interval Gastric Cancers at Screening Gastroscopy.

Jin Hwa Park1, Kang Nyeong Lee1, Hang Lak Lee1, Dae Won Jun1, Jai Hoon Yoon1, Oh Young Lee1, Byung Chul Yoon1, Ho Soon Choi1.   

Abstract

BACKGROUNDS/AIMS: Interval gastric cancers (GCs) can be encountered during screening gastroscopy. This study investigated the rate of interval GCs and their risk factors.
MATERIALS AND METHODS: We retrospectively investigated subjects who underwent screening gastroscopy from 2005 to 2017 in a university hospital and were diagnosed with GC. Subjects were grouped based on their endoscopic images and descriptive results into interval GC and initially diagnosed GC groups. Interval GCs were defined when endoscopic results within the previous 3 years were negative for GC. The clinico-pathological characteristics of the groups and risk factors for interval GCs were evaluated.
RESULTS: Of 54 724 subjects who underwent screening gastroscopy, 234 were diagnosed with GC, of which 43 were interval GCs. The rate of interval GCs was 18.4% (43/234, mean age 61.6 years). Interval GCs were smaller than initially diagnosed GCs (1.6 vs 1.9 cm, P = .011). They were located in the low-to-mid-body in 44.2%, antrum in 48.8%, and high body and cardia in 7%. Their observation time was shorter (248.74 vs 410.64 sec, P = .032). In multivariate analysis, they were associated with short observation time (odds ratio [OR] 0.99, 95% CI 0.994-0.998, P < .001) and location in the low-to-mid-body (OR 2.12, 95% CI 1.071-4.181, P = .031), although differentiation, ulcerated type, metaplasia, Helicobacter pylori infection, and endoscopists' experience were not associated with interval GCs.
CONCLUSIONS: The rate of interval GCs was significant during screening gastroscopy. They might be reduced by increasing observation time, focusing on smaller lesions, and observing the low-to-mid-body of the stomach more carefully.

Entities:  

Mesh:

Year:  2021        PMID: 33960944      PMCID: PMC8975297          DOI: 10.5152/tjg.2021.20129

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  33 in total

1.  Comparing mass screening techniques for gastric cancer in Japan.

Authors:  Atsushi Tashiro; Masatoshi Sano; Koichi Kinameri; Kazutaka Fujita; Yutaka Takeuchi
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

2.  Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy.

Authors:  O Hosokawa; S Tsuda; E Kidani; K Watanabe; Y Tanigawa; S Shirasaki; H Hayashi; T Hinoshita
Journal:  Endoscopy       Date:  1998-10       Impact factor: 10.093

3.  Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: a case-control study.

Authors:  Eun Jeong Gong; Ji Yong Ahn; Hwoon-Yong Jung; Hyun Lim; Kwi-Sook Choi; Jeong Hoon Lee; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Jin-Ho Kim; Son Yeong Choi; Jae Won Choe; Min-Ju Kim
Journal:  J Gastroenterol Hepatol       Date:  2014-02       Impact factor: 4.029

4.  Risk factors of developing interval early gastric cancer after negative endoscopy.

Authors:  Young Sin Cho; Il-Kwun Chung; Ji Hyun Kim; Yunho Jung; Tae Hoon Lee; Sang-Heum Park; Sun-Joo Kim
Journal:  Dig Dis Sci       Date:  2014-10-15       Impact factor: 3.199

5.  Rate and Predictors of Interval Esophageal and Gastric Cancers after Esophagogastroduodenoscopy in the United States.

Authors:  Yize R Wang; Edward V Loftus; Thomas A Judge; Steven R Peikin
Journal:  Digestion       Date:  2016-11-22       Impact factor: 3.216

6.  Diagnostic value of blue laser imaging combined with magnifying endoscopy for precancerous and early gastric cancer lesions.

Authors:  Yang Zhenming; Shen Lei
Journal:  Turk J Gastroenterol       Date:  2019-06       Impact factor: 1.852

7.  Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry.

Authors:  Keiichi Maruyama; Michio Kaminishi; Ken-Ichi Hayashi; Yoh Isobe; Ichiro Honda; Hitoshi Katai; Kuniyoshi Arai; Yasuhiro Kodera; Atsushi Nashimoto
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

8.  Importance of the site of endoscopic gastric biopsy in ulcerating lesions of the stomach.

Authors:  A R Hatfield; G Slavin; A W Segal; A J Levi
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

9.  Quality indicators for colonoscopy and the risk of interval cancer.

Authors:  Michal F Kaminski; Jaroslaw Regula; Ewa Kraszewska; Marcin Polkowski; Urszula Wojciechowska; Joanna Didkowska; Maria Zwierko; Maciej Rupinski; Marek P Nowacki; Eugeniusz Butruk
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

10.  A cohort study of missed and new cancers after esophagogastroduodenoscopy.

Authors:  Spiro C Raftopoulos; Dev S Segarajasingam; Valerie Burke; Hooi C Ee; Ian F Yusoff
Journal:  Am J Gastroenterol       Date:  2010-01-12       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.